Matthew McManus
Vermogen: 397 471 $ op 31-05-2026
Vermogen: 397 471 $ op 31-05-2026
Matthew F.
McManus is currently Chairman at Ansa Biotechnologies, Inc. since 2023.
Former roles include President, Chief Executive Officer & Director at PrimeraDx, Inc. from 2010 to 2014; President, Chief Executive Officer & Director at Asuragen, Inc. from 2014 to 2021; Chief Operating Officer & Executive Vice President at Azenta, Inc. in 2022; COO-Pathology and Laboratory Medicine Institute at The Cleveland Clinic Foundation in 2010; President-Diagnostics & Spatial Biology Segment at Bio-Techne Corp.
from 2024 to 2026; Manager-Business Unit at Procter & Gamble Co.; Management Consultant at McKinsey & Co., Inc.; and Medical Scientist at Novartis Institutes for Biomedical Research, Inc. Education includes undergraduate studies at College of the Holy Cross (Massachusetts), an MBA from Boston College, and a doctorate from the University of Pennsylvania Medical Center.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-02-2026 | 7.691 ( 0% ) | 397 471 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
Ansa Biotechnologies, Inc.
Ansa Biotechnologies, Inc. BiotechnologyHealth Technology Develops novel DNA synthesis technology | Voorzitter | 22-02-2023 |
| Bedrijven | Functie | Einde |
|---|---|---|
| BIO-TECHNE CORPORATION | Corporate Officer/Principal | 01-03-2026 |
| AZENTA, INC. | Operationeel Directeur | 14-10-2022 |
Asuragen, Inc.
Asuragen, Inc. Medical SpecialtiesHealth Technology Develops molecular diagnostic products | Algemeen Directeur | - |
The Cleveland Clinic Foundation
The Cleveland Clinic Foundation Medical/Nursing ServicesHealth Services Provides healthcare services | Corporate Officer/Principal | 02-01-2010 |
| PROCTER & GAMBLE COMPANY | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 12 |
|---|---|
Procter & Gamble Co.
Procter & Gamble Co. Household/Personal CareConsumer Non-Durables Manufactures and sells fabric & home care products, diapers, baby wipes, tissues, toilet paper, hair, skin and personal care, toothbrushes, vitamins, supplements & razors | Consumer Non-Durables |
Bio-Techne Corp.
Bio-Techne Corp. BiotechnologyHealth Technology Manufactures and sells biological products | Health Technology |
Azenta, Inc.
Azenta, Inc. Medical/Nursing ServicesHealth Services Provides gene sequencing and gene synthesis services and develops automated ultra-cold storage systems | Health Services |
PrimeraDx, Inc.
PrimeraDx, Inc. Medical SpecialtiesHealth Technology Develops and commercializes molecular diagnostics systems | Health Technology |
Asuragen, Inc.
Asuragen, Inc. Medical SpecialtiesHealth Technology Develops molecular diagnostic products | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
College of the Holy Cross (Massachusetts)
College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
The Cleveland Clinic Foundation
The Cleveland Clinic Foundation Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
University of Pennsylvania Medical Center
University of Pennsylvania Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ansa Biotechnologies, Inc.
Ansa Biotechnologies, Inc. BiotechnologyHealth Technology Develops novel DNA synthesis technology | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau